FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research has raised the target price for Schott Pharma from 35 to 37 euros and left the rating at "Buy". The pharmaceutical packaging supplier has provided a much-needed positive surprise with the publication of its results, analyst Falko Friedrichs wrote in a study published on Tuesday. This is an important step towards a recovery./tih/la

Publication of the original study: 02.07.2024 / 07:57 / CET

First dissemination of the original study: Date not specified in study / Time not specified in study / CET

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------